IDEXX Laboratories (IDXX) Stock Analysis
This is a peer-relative look at IDEXX Laboratories (IDXX): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Health Care Equipment & Services peers, so every number reads in context rather than in isolation.
Company Profile
| Profile Item | IDXX |
|---|---|
| Name | IDEXX Laboratories, Inc. |
| Country/Region | United States |
| GICS Sector | Health Care |
| GICS Industry Group | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment |
| Market Capitalization | 53.26 billion USD |
| Currency | USD |
| Exchange | Nasdaq |
| Listing Date | June 21, 1991 |
| Security Type | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | Current stock: IDXX | Industry group median |
|---|---|---|
| Total Return (1Y) | -1.84% | 21.53% |
| Total Return (3Y, Annualized) | 18.42% | 9.81% |
| Total Return (5Y, Annualized) | 2.02% | -2.76% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | Current stock: IDXX | Industry group median |
|---|---|---|
| Volatility (1Y, Annualized) | 37.02% | 50.93% |
| Beta (5Y) | 1.44 | 0.85 |
| Max Drawdown (5Y) | -50.91% | -70.34% |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | Current stock: IDXX | Industry group median |
|---|---|---|
| Sharpe Ratio (1Y) | -0.17 | 0.34 |
| Sortino Ratio (1Y) | -0.28 | 0.54 |
Profitability
ROE (TTM)
IDEXX Laboratories (IDXX) posts ROE of 68.93%, above the industry benchmark range. Equity is being turned into profit at an exceptional rate, but very high ROE should still be checked against leverage, buybacks, and the size of the equity base.
IDXX
Health Care Equipment & Services industry group
68.93%
Group distribution
- IDXX
- 68.93%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Largest peers
- IDXX
- 68.93%
- ISRG
- 17.93%
- SYK
- 16.02%
- UNH
- 15.77%
- MDT
- 10.65%
- ABT
- 9.14%
- MCK
- --
Net Margin (TTM)
IDEXX Laboratories (IDXX) keeps 25.36% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.
IDXX
Health Care Equipment & Services industry group
25.36%
Group distribution
- Max
- 29.35%
- IDXX
- 25.36%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Largest peers
- ISRG
- 25.54%
- IDXX
- 25.36%
- MDT
- 13.93%
- SYK
- 13.78%
- ABT
- 9.75%
- UNH
- 3.53%
- MCK
- 1.12%
Operating Margin (TTM)
IDEXX Laboratories (IDXX) turns 33.14% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.
IDXX
Health Care Equipment & Services industry group
33.14%
Group distribution
- Max
- 35.43%
- IDXX
- 33.14%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Largest peers
- ISRG
- 33.29%
- IDXX
- 33.14%
- SYK
- 22.96%
- MDT
- 19.33%
- ABT
- 11.66%
- UNH
- 5.82%
- MCK
- 1.48%
Profitability Metrics
| Metric | Current stock: IDXX | Industry group median |
|---|---|---|
| ROE (TTM) | 68.93% | 5.45% |
| ROA (TTM) | 26.70% | 3.17% |
| Net Margin (TTM) | 25.36% | 2.18% |
| Operating Margin (TTM) | 33.14% | 6.81% |
| Gross Margin (TTM) | 62.72% | 55.21% |
Growth
Revenue Growth
IDEXX Laboratories (IDXX) grew revenue 10.42%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.
EPS Growth
IDEXX Laboratories (IDXX) grew earnings per share 22.59%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.
Growth Metrics
| Metric | Current stock: IDXX | Industry group median |
|---|---|---|
| Revenue Growth (YoY) | 10.42% | 11.55% |
| Revenue Growth (3Y CAGR) | 8.52% | 10.83% |
| EPS Growth (YoY) | 22.59% | 4.88% |
| EPS Growth (3Y CAGR) | 17.66% | 14.59% |
Financial Strength
Current Ratio (MRQ)
IDEXX Laboratories (IDXX) has current ratio of 1.19, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.
IDXX
Health Care Equipment & Services industry group
1.19
Group distribution
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- IDXX
- 1.19
- Min
- 0.30
Largest peers
- ISRG
- 3.33
- SYK
- 2.18
- MDT
- 2.07
- ABT
- 1.46
- IDXX
- 1.19
- MCK
- 0.90
- UNH
- 0.74
Debt / Equity (MRQ)
IDEXX Laboratories (IDXX) has debt-to-equity ratio of 0.52, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.
IDXX
Health Care Equipment & Services industry group
0.52
Group distribution
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- IDXX
- 0.52
- Q1
- 0.16
- Min
- 0.00
Largest peers
- UNH
- 0.70
- SYK
- 0.66
- ABT
- 0.61
- MDT
- 0.55
- IDXX
- 0.52
- ISRG
- --
- MCK
- --
Financial Strength Metrics
| Metric | Current stock: IDXX | Industry group median |
|---|---|---|
| Current Ratio (MRQ) | 1.19 | 1.98 |
| Debt / Equity (MRQ) | 0.52 | 0.58 |
| Net Debt / EBITDA | 0.46 | 2.04 |
Dividends
Dividend Yield (TTM)
IDEXX Laboratories (IDXX) pays no dividend, leaving dividend yield at 0.00% this period. Shareholders may still receive value through reinvestment or buybacks, but there is no dividend income to compare here.
IDXX
Health Care Equipment & Services industry group
0.00%
Group distribution
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- MDT
- 2.72%
- UNH
- 2.29%
- ABT
- 2.22%
- SYK
- 1.05%
- MCK
- 0.32%
- IDXX
- 0.00%
- ISRG
- 0.00%
Dividend Payout Ratio (TTM)
IDEXX Laboratories (IDXX) paid no earnings out as dividends this period, leaving payout ratio at 0.00%. There is no dividend payout to size against earnings.
IDXX
Health Care Equipment & Services industry group
0.00%
Group distribution
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- ABT
- 92.54%
- MDT
- 70.02%
- UNH
- 51.71%
- SYK
- 37.49%
- MCK
- 8.77%
- IDXX
- 0.00%
- ISRG
- 0.00%
Dividend Metrics
| Metric | Current stock: IDXX | Industry group median |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
IDEXX Laboratories (IDXX) trades at P/E ratio of 45.56, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.
IDXX
Health Care Equipment & Services industry group
45.56
Group distribution
- Max
- 80.41
- Q3
- 47.62
- IDXX
- 45.56
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
Largest peers
- ISRG
- 54.75
- IDXX
- 45.56
- ABT
- 41.02
- SYK
- 34.70
- MCK
- 27.36
- MDT
- 25.01
- UNH
- 22.50
P/S Ratio (TTM)
IDEXX Laboratories (IDXX) trades at 11.42 on P/S ratio, above the industry benchmark range. The stock is being valued at an unusually rich price per dollar of trailing revenue.
IDXX
Health Care Equipment & Services industry group
11.42
Group distribution
- IDXX
- 11.42
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
Largest peers
- ISRG
- 13.82
- IDXX
- 11.42
- SYK
- 4.72
- ABT
- 3.95
- MDT
- 3.47
- UNH
- 0.78
- MCK
- 0.29
P/B Ratio (MRQ)
IDEXX Laboratories (IDXX) trades at 28.50 on P/B ratio, above the industry benchmark range. Investors are putting an unusually rich price on each dollar of book equity relative to peers.
IDXX
Health Care Equipment & Services industry group
28.50
Group distribution
- IDXX
- 28.50
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Largest peers
- IDXX
- 28.50
- ISRG
- 9.82
- SYK
- 5.29
- ABT
- 3.73
- UNH
- 3.60
- MDT
- 2.59
- MCK
- -30.85
Valuation Metrics
| Metric | Current stock: IDXX | Industry group median |
|---|---|---|
| P/E Ratio (TTM) | 45.56 | 29.93 |
| P/S Ratio (TTM) | 11.42 | 2.13 |
| P/B Ratio (MRQ) | 28.50 | 3.00 |
| Free Cash Flow Yield (TTM) | 2.00% | 3.50% |